Cannabis Industry 2026: Strategic Growth and Investment Landscape
The cannabis industry is on the cusp of a transformative 2026, with market dynamics increasingly favoring strategic growth and discerning investment. Recent analyses underscore a robust expansion,…
Investing in Cannabis Biotech: The Next Frontier
Cannabis biotech offers precision medicine, synthetic cannabinoids, and genetic advancements for long-term growth.
Cannabis Drinks as an Alcohol Alternative: Investment Outlook
Cannabis drinks emerging as a potential safer alternative to alcohol, reducing negative consequences.
The CBD Clock Is Ticking: Regulatory Deadlines and Market Opportunity
Federal hemp law changes in November 2026 could make millions of CBD products illegal—a major threat to the multi-billion-dollar CBD market.
Massachusetts Tops $9B in Legal Cannabis Sales: What It Means for Investors
Massachusetts legal cannabis market surpasses $9 billion in total sales since 2018; $1.65 billion in 2025 alone.
Big Claims, Thin Evidence: Separating Cannabis Hype from Real Returns
New research reveals major gap between popular medical cannabis use and clinical evidence supporting its effectiveness.
Why Cannabis Biotech Is the Next Investment Frontier
As the broader cannabis market matures, astute investors are increasingly looking beyond traditional cultivation and retail to the burgeoning field of cannabis biotechnology. This sector, focused on…
New York Cannabis Market Shaken by Major Product Recall Over Unreliable Lab Testing
New York’s Office of Cannabis Management has issued a precautionary recall for 54 adult-use cannabis product lots and one heavy metal product lot, citing unreliable testing results from Keystone…
Safe Harbor Financial Rides Wave of Growth in Emerging US Cannabis Markets
Safe Harbor Financial reports a robust 29% year-over-year growth in emerging U.S. cannabis markets, driven by strategic early entry into key states and over 100 new customer accounts, signaling a…
Psychedelic and Cannabis Investment Convergence: R&D and Biotech Opportunities
The shift towards psychedelic research and therapy signals a more mature and specialized phase for alternative medicine investment. Companies with strong R&D, patent portfolios, and clinical…